BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9926231)

  • 1. Epstein-Barr virus in Hodgkin's disease.
    Chapman AL; Rickinson AB
    Ann Oncol; 1998; 9 Suppl 5():S5-16. PubMed ID: 9926231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas.
    Cader FZ; Kearns P; Young L; Murray P; Vockerodt M
    Cancer Treat Rev; 2010 Jun; 36(4):348-53. PubMed ID: 20193983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.
    Cohen JI
    Semin Hematol; 2003 Apr; 40(2):116-23. PubMed ID: 12704588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy for Epstein-Barr virus-associated cancers in children.
    Straathof KC; Bollard CM; Rooney CM; Heslop HE
    Oncologist; 2003; 8(1):83-98. PubMed ID: 12604735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-associated lymphoproliferative disorders.
    Grywalska E; Markowicz J; Grabarczyk P; Pasiarski M; Roliński J
    Postepy Hig Med Dosw (Online); 2013 May; 67():481-90. PubMed ID: 23752600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
    Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive cell therapy against EBV-related malignancies: a survey of clinical results.
    Merlo A; Turrini R; Dolcetti R; Zanovello P; Amadori A; Rosato A
    Expert Opin Biol Ther; 2008 Sep; 8(9):1265-94. PubMed ID: 18694349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options for post-transplant lymphoproliferative disorder and other Epstein-Barr virus-associated malignancies.
    Davis JE; Moss DJ
    Tissue Antigens; 2004 Apr; 63(4):285-92. PubMed ID: 15009802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus associated lymphoproliferations in the AIDS setting.
    Ambinder RF
    Eur J Cancer; 2001 Jul; 37(10):1209-16. PubMed ID: 11423253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and progression of human lymphoproliferative lesions by Epstein-Barr virus.
    Chappuis BB; Müller-Hermelink HK
    Environ Health Perspect; 1990 Aug; 88():237-41. PubMed ID: 2176977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV-associated neoplasms: alternative pathogenetic pathways.
    Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Schwarzmann F; Wolf H; Minarovits J
    Med Hypotheses; 2004; 62(3):387-91. PubMed ID: 14975509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epstein-Barr Virus Genome Replication as a Molecular Target for Cancer Therapy].
    Noguchi K
    Yakugaku Zasshi; 2019; 139(1):63-67. PubMed ID: 30606931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biology of the Epstein-Barr virus].
    Morand P; Seigneurin JM
    Ann Biol Clin (Paris); 1989; 47(7):421-7. PubMed ID: 2554764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-associated lymphoproliferative disorders.
    Rezk SA; Weiss LM
    Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
    Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
    J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus: the first human tumor virus and its role in cancer.
    Pagano JS
    Proc Assoc Am Physicians; 1999; 111(6):573-80. PubMed ID: 10591086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T cell responses in the immune control against latent infection by Epstein-Barr virus.
    Paludan C; Münz C
    Curr Mol Med; 2003 Jun; 3(4):341-7. PubMed ID: 12776989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas.
    Kennedy G; Komano J; Sugden B
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14269-74. PubMed ID: 14603034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for Epstein-Barr virus-associated malignancies.
    Long HM; Parsonage G; Fox CP; Lee SP
    Drug News Perspect; 2010 May; 23(4):221-8. PubMed ID: 20520851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hodgkin's disease and Epstein-Barr virus].
    Depil S; Moralès O; Auriault C
    Ann Biol Clin (Paris); 2004; 62(6):639-48. PubMed ID: 15563422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.